Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Takeda
Company Monitoring Page for Takeda
latest headlines for company on cafepharma
Will Takeda Buy Salix?
Seeking Alpha
Mon, 12/19/16 - 10:56 am
Tags:
Takeda
,
Salix
,
M&A
Standing Up To The Test Of Time: Two Cancer Drugs That Could Survive A Hobbled FDA
Forbes
Thu, 12/8/16 - 09:59 am
Tags:
FDA
,
Seattle Genetics
,
Takeda
,
Adcetris
,
Hodgkin's lymphoma
,
AbbVie
,
JNJ
,
Ibruvica
,
mantle cell lymphoma
Valeant: The Salix Sale Debacle
Seeking Alpha
Mon, 12/5/16 - 10:42 pm
Tags:
Valeant Pharmaceuticals
,
Salix
,
M&A
,
Takeda
Valeant: Don't WrIte Off Salix's Sale Potential
Seeking Alpha
Thu, 12/1/16 - 04:27 pm
Tags:
Valeant Pharmaceuticals
,
hirings
,
Salix
,
Takeda
,
M&A
Valeant in talks to sell Salix stomach-drug unit in $10 billion deal
Reuters
Wed, 11/2/16 - 11:04 am
Tags:
Valeant Pharmaceuticals
,
Salix
,
M&A
,
Takeda
A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
Stat
Fri, 10/14/16 - 11:42 am
Tags:
Crohn’s disease
,
HIV
,
vedolizumab
,
Entyvio
,
Takeda
Takeda broadens oncology pipeline with Crescendo deal
BioPharma Dive
Tue, 10/11/16 - 09:22 pm
Tags:
Takeda
,
Crescendo Biologics
,
Humabody
,
R&D
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Tags:
Amgen
,
Multiple Myeloma
,
Kyprolis
,
clinical trials
,
Takeda
,
Velcade
Takeover Chatter Around Clovis May Be Overdone
TheStreet.com
Fri, 09/23/16 - 10:10 pm
Tags:
Clovis Oncology
,
M&A
,
Eli Lilly
,
Merck
,
Takeda
So Takeda wants to do up to $20B in M&A? Welcome to the bidding war for US biotechs
Endpoints
Wed, 09/14/16 - 09:12 am
Tags:
M&A
,
Takeda
,
biotech
Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul
Endpoints
Tue, 09/13/16 - 12:56 pm
Tags:
Takeda
,
reorganization
,
R&D
,
CROs
Takeda Pharmaceuticals enters race for a Zika vaccine
Stat
Thu, 09/1/16 - 04:45 pm
Tags:
vaccines
,
Zika virus
,
Takeda
Takeda rests its R&D footprint on U.S. hubs
Endpoints
Wed, 08/3/16 - 10:57 am
Tags:
Takeda
,
R&D
Ex-Allergan CEO David Pyott backs a biotech startup alongside Takeda, PhI trial set to launch
Endpoints
Mon, 08/1/16 - 09:44 am
Tags:
Allergan
,
David Pyott
,
biotech
,
Takeda
,
Bioniz
,
peptide platform
Takeda Q1 earnings soar as plans to speed R&D rejig announced
Fierce Pharma
Fri, 07/29/16 - 08:42 pm
Tags:
Takeda
,
earnings
Takeda begins field testing norovirus vaccine
BioPharma Dive
Tue, 06/21/16 - 11:18 am
Tags:
Takeda
,
norovirus
,
vaccines
,
TAK-214
,
clinical trials
Takeda joins Celgene on M2Gen’s clinical and molecular cancer data sharing program
Fierce Biotech
Sat, 06/18/16 - 09:21 am
Tags:
Takeda
,
Celgene
,
M2Gen
,
data sharing
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders
Yahoo
Wed, 06/8/16 - 09:58 am
Tags:
Takeda
,
Theravance
,
TD-8954
,
gastrointestinal motility disorders
J&J myeloma drug, in combo regimen, delays worsening of the disease
Yahoo/Reuters
Sun, 06/5/16 - 12:01 pm
Tags:
JNJ
,
Multiple Myeloma
,
Darzalex
,
Takeda
,
Velcade
,
ASCO 2016
Valeant Rises After Reported Rejection of Takeda-TPG Takeover
Bloomberg
Fri, 05/27/16 - 12:38 pm
Tags:
Valeant Pharmaceutcals
,
M&A
,
Takeda
,
TPG
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.